Study on the T-Cell Immune Response in Individuals With HIV and Toxoplasmosis Using ELISPOT
Conclusion: It is important to monitor patients with HIV, toxoplasmosis, and immunodeficiency. This can help prevent complications such as TE. A modified ELISPOT protocol may be required to determine the specific cell-mediated response in immunocompromised patients.
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Interdisciplinary Perspectives on Infectious Diseases |
| Online Access: | http://dx.doi.org/10.1155/ipid/9514227 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|